Tech Center 1600 • Art Units: 1615 1644 1674
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18719447 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy